ADAMS ERIC A
SEC insider (Form 3/4/5 filer). CIK 0001817882. President & CEO at InMed Pharmaceuticals Inc. (INM). 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 19, 2025. Located in VANCOUVER, A1.
Companies ADAMS ERIC A has filed insider reports for
- InMed Pharmaceuticals Inc. (INM): Director, Officer, President & CEO
ADAMS ERIC A
CIK: 0001817882
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
InMed Pharmaceuticals Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Dec 19, 2025INM
InMed Pharmaceuticals Inc.
AwardDirectEmployee Stock Option (Right to Buy)
35K shares- - Dec 15, 2025INM
InMed Pharmaceuticals Inc.
Expiration (Short)DirectEmployee Stock Option (Expiration)
250 shares- - Dec 20, 2024INM
InMed Pharmaceuticals Inc.
AwardDirectEmployee Stock Option (Right to Buy)
6.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 19, 2025 | INM InMed Pharmaceuticals Inc. | Award Employee Stock Option (Right to Buy) | 35,000 | - | - | Direct |
| Dec 15, 2025 | INM InMed Pharmaceuticals Inc. | Expiration (Short) Employee Stock Option (Expiration) | 250 | - | - | Direct |
| Dec 20, 2024 | INM InMed Pharmaceuticals Inc. | Award Employee Stock Option (Right to Buy) | 6,250 | - | - | Direct |
1-3 of 3 transactions